Clinical Drug Development & Investigations
Tao Long, PhD
Clinical Pharmacologist, Quantitative Clinical Pharmacology
Takeda Pharmaceutical Co Ltd
Daisy Zhu, PharmD, PhD (she/her/hers)
Clinical Pharmacology Lead, Immunology & Inflammation
Pfizer Inc
William Denney, PhD (he/him/his)
Chief Scientist
Human Predictions LLC
Eliford Kitabi, PhD
Pharmacometrician
US Food & Drug Administration
Michael Neely, MD
Professor of Pediatrics & Clinical Scholar, Keck School of Medicine, Pediatrics
Univ of Southern California
Wenping Wang, PhD
Senior Director, Pharmacometrics, Quantitative Clinical Pharmacology
Takeda Pharmaceutical Co Ltd
This Workshop will be useful for beginner to intermediate-level R users and can range from doctorate-level students (MD, PharmD, PhD) to postdoctoral fellows and early-stage professionals. The audience should have a foundational understanding of how to leverage pharmacometrics skills to inform drug development decisions. The target audience may either handle clinical data on a daily basis or are interested in enhancing their skills in applying state-of-the-art data and pharmacometrics analysis methods in drug development and patient care.
Co-Chair & Faculty: Daisy Zhu, PharmD, PhD (she/her/hers) – Pfizer Inc
Faculty: Michael Neely, MD – Univ of Southern California
Faculty: William S. Denney, PhD (he/him/his) – Human Predictions LLC
Faculty: Wenping Wang, PhD – Takeda Pharmaceutical Co Ltd
Co-Chair & Faculty: Tao Long, PhD – Takeda Pharmaceutical Co Ltd
Faculty: Eliford Kitabi, PhD – US Food & Drug Administration